Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

Enzymatica

1.95 SEK

+1.57 %

Less than 1K followers

ENZY

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+1.57 %
+0.26 %
-18.28 %
-33.39 %
+23.10 %
+19.33 %
-47.42 %
-89.53 %
-65.95 %

Enzymatica is a life science company that develops and sells medical devices against infectious diseases. The products are based on barrier technology, which includes marine enzymes. The company's first product is ColdZyme® Mouth Spray, which can prevent colds and shorten the duration of the illness. The product has been launched in several markets and the strategy is to expand to more markets through partners. The head office is located in Lund.

Read more
Market cap
472.12M SEK
Turnover
56.07K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
18.2.
2026

Annual report '25

28.4.
2026

Interim report Q1'26

7.5.
2026

General meeting '26

All
Press releases
3rd party
ShowingAll content types
Press release11/26/2025, 9:46 AM

BioStock: Enzymatica enters partnership with the UK Sports Institute to strengthen elite athlete health

Enzymatica
Press release11/20/2025, 7:30 AM

Enzymatica AB: Enzymatica enters partnership with the UK Sports Institute to support athlete health and performance

Enzymatica
Press release11/4/2025, 2:13 PM

BioStock: Enzymatica’s CEO steps down after four years – summarizes a journey from science to commercialization

Enzymatica

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Regulatory press release10/30/2025, 7:30 AM

Enzymatica AB: Quarterly report Q3/2025: Strong development in Sweden and continued focus on international expansion

Enzymatica
Press release10/15/2025, 7:17 AM

BioStock: Enzymatica launches new ColdZyme flavour

Enzymatica
Press release10/14/2025, 7:25 AM

Enzymatica AB: ColdZyme launches a refreshing new flavour - Eucalyptus

Enzymatica
Regulatory press release10/13/2025, 8:00 AM

Enzymatica AB: Enzymatica appoints Holger Lembrér as new CFO

Enzymatica
Press release10/1/2025, 11:00 AM

Enzymatica AB: Enzymatica to Support Swedish Biathlon Federation as Official Supplier

Enzymatica
Regulatory press release8/22/2025, 11:50 AM

Bulletin from the Extraordinary General Meeting of Enzymatica AB (publ) on 22 August 2025

Enzymatica
Regulatory press release8/12/2025, 6:00 AM

Sana Alajmovic appointed new CEO of Enzymatica AB

Enzymatica
Regulatory press release8/6/2025, 6:30 AM

Notice of Extraordinary General Meeting in Enzymatica AB (publ)

Enzymatica
Regulatory press release7/17/2025, 6:30 AM

Enzymatica AB: Quarterly report Q2/2025: Strong development in Sweden and increased international activity

Enzymatica
Press release7/14/2025, 2:32 PM

BioStock: Enzymatica’s CEO comments on his resignation

Enzymatica
Press release6/30/2025, 6:15 AM

Enzymatica AB: Enzymatica's CFO Therese Filmersson to leave her position

Enzymatica
Regulatory press release6/26/2025, 10:15 AM

Enzymatica AB: Claus Egstrand steps down as CEO of Enzymatica

Enzymatica
Press release5/14/2025, 1:10 PM

BioStock: The science behind ColdZyme – Insights from professors

Enzymatica
Regulatory press release5/7/2025, 1:44 PM

Bulletin from the annual general meeting of Enzymatica AB (publ) on May 7, 2025

Enzymatica
Press release5/5/2025, 9:15 AM

Enzymatica AB: BioStock: Enzymatica gears up for global expansion after a strong first quarter

Enzymatica
Regulatory press release4/29/2025, 6:30 AM

Enzymatica AB: Quarterly report Q1/2025: Enzymatica strengthens its position in home markets and focuses on international expansion

Enzymatica
Regulatory press release4/2/2025, 12:45 PM

Notice of Annual General Meeting 2025 in Enzymatica AB (publ)

Enzymatica
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.